PharmaShots | Incisive News in 3 Shots

Subscribe Now

Calidi Biotherapeutics

Calidi Biotherapeutics and City of Hope Report the First Patient Dosing of CLD-101 in the P-I Trial for Recurrent High-Grade Glioma

Calidi Biotherapeutics and City of Hope Report the First Patient Dosing of CLD-101 in the P-I Trial for Recurrent High-Grade Gliom...

July 19, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us